Posts Tagged ‘phase’
Baxter Presents Clinical Efficacy Results From Phase III Study Of Seasonal Flu Vaccine
Baxter International Inc. (NYSE:BAX), in conjunction with DynPort Vaccine Company LLC (DVC), a CSC Company (NYSE:CSC), presented Phase III study data measuring the clinical efficacy for PREFLUCEL, a trivalent seasonal influenza candidate vaccine. PREFLUCEL is made using Baxter’s Vero cell culture platform and does not contain an adjuvant or preservatives…
Pharmacy Swine Flu Trial Moves Into Phase II – Pharmaceutical Society Of Australia
The first phase of a swine flu vaccination program trial conducted in Tasmania by the Pharmaceutical Society of Australia and the Department of Health and Human Services has proved popular with the community. Phase II of the pandemic vaccination program will now be rolled out to allow pharmacy-based clinics to support other elements of the swine flu vaccination program…
PositiveID Corporation Successfully Completes Phase I Development Of Its Rapid Virus Detection System
PositiveID Corporation (“PositiveID” or the “Company”) (NASDAQ:PSID), in conjunction with its development partner RECEPTORS LLC (“Receptors”), announced today that it has successfully completed Phase I development of its rapid virus detection system, a non-invasive, point-of-care test to test patient samples and identify various forms of influenza within minutes…
Alkermes Announces Positive Results For Phase 1 Study Of New Drug Candidate For Treatment Of Opioid-Induced Constipation
Alkermes, Inc. (NASDAQ: ALKS) announced positive topline data from a phase 1 clinical study of ALKS 37, an orally active, peripherally-restricted opioid antagonist with potential to block the effects of opioid agonists on gastrointestinal motility, commonly referred to as opioid-induced constipation (OIC)…
Amarillo Biosciences Announces Australian Phase 2 Oral Interferon Clinical Trial Indicates Benefit In Preventing Influenza-Like Illness In Seniors
Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) announced additional preliminary results from the recently completed Phase 2 clinical trial conducted in Perth, Australia at the University of Western Australia with Professors David Smith and Manfred Beilharz as principal investigators…
Trigemina Conducting Phase IIa Clinical Trial In Chronic Daily Headache
Trigemina, Inc. (TI), a Mountain View based startup, has begun a Phase IIa clinical trial for its lead molecule in Chronic Daily Headache (CDH) in collaboration with Dr. Egilius Spierings at MedVadis Research Corporation located outside of Boston. The study compares intranasal oxytocin with placebo in patients suffering from at least 15 days of headache pain per month…
Third Party Reexamination Of Javelin Pharmaceuticals’ Phase III Trial Data For Ereska Yields Statistically Significant Primary Endpoint
Javelin Pharmaceuticals, Inc. (NYSE Amex: JAV – News) announced that a reexamination conducted by a third party of pain score measurements from its Phase III study of Ereska? (intranasal ketamine) showed that top line results for its primary endpoint were statistically significant…
QRxPharma Initiates Second Pivotal Phase 3 Study Of MoxDuo(TM)IR Dual-Opioid(TM) For NDA Submission
QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced initiation of its second pivotal Phase 3 registration trial (Study 009) to evaluate analgesic efficacy and safety of MoxDuo?IR, a patented 3:2 ratio fixed dose combination of morphine plus oxycodone…
Phosphagenics Announces Positive Results From Phase 1B Study Of Transdermal Oxycodone Patch
Phosphagenics Limited (“Phosphagenics”) (ASX: POH; OTCQX: PPGNY) today announced positive results from a Phase 1B clinical study using the Company’s patented TPM? (Targeted Penetration Matrix) for the transdermal delivery of oxycodone…
Bharat Biotech Begins Phase I Clinical Trials Of HN-VAC – Its Cell Culture H1N1 Vaccine
Bharat Biotech today announced that it has commenced Phase I clinical evaluation of HN-VAC, its cell culture based H1N1 vaccine candidate. Bharat Biotech received the nod from Drugs Controller General of India (DCGI) to conduct the Phase I clinical trials…
Rx Drug Compare
Translator
By N2H